Latest news with #HBNC
Mint
14 hours ago
- Health
- Mint
These innovative, made-in-India health tech products are saving lives
For Sanjita Paswan, an ASHA (Accredited Social Health Activist) worker at the Primary Health Center in Dabhel, Daman, carrying a heavy weighing machine up and down multiple floors was once part of her daily routine. To fulfill the requirements of the Home-Based Newborn Care (HBNC) program, she would use the machine to weigh newborns—often a time-consuming and delicate task. Thanks to artificial intelligence, that process has been transformed. Instead of lugging equipment around, Sanjita now simply takes a 15-second video of the baby using her smartphone. In just minutes, vital anthropometric data—including weight, length, head circumference, chest circumference, and mid-upper arm circumference—is automatically recorded. This breakthrough is powered by Shishu Maapan, an AI-enabled tool developed by Wadhwani AI, revolutionizing how newborn health is monitored across India. Shishu Maapan is amongst the many health tech innovations being made in India to meet the country's healthcare needs locally. With a population exceeding 1.4 billion, India faces distinct healthcare challenges that global solutions alone can't address. Most international innovations lack the affordability, accessibility, and local relevance essential to meet the country's unique needs. Indian start-ups are rising to the occasion and are constantly coming up with innovative products which is ensuring the rapid expansion of the health tech sector in the country. Joysoles Socks Who knew something as simple as a pair of socks could be a small but mighty health tool in managing diabetes symptoms? Joysoles designs high-performance foot care products for women with their proprietary GuardianWeave fabric technology. They offer two products-the Non-Binding Diabetic socks and Compression socks. The non-binding diabetic socks are stretchy and boast a non-binding design that does not restrict blood flow. These socks are designed to protect your feet from neuropathy with a reinforced performance footbed. They also claim to reduce the risk of infections with its antimicrobial and antifungal properties. The compression socks meanwhile offer a mild graduated compression which enhances blood circulation and leg support. Offering graduated compression, these socks help reduce swelling, improve energy, and prevent varicose veins. Designed for daily wear, these socks are readily available on their website. Sunflox-Spandan One of the biggest challenges in India is timely and accessible cardiac care. Launched in 2016, Spandan is a compact, matchbox-sized portable ECG device that turns any smartphone into a clinical-grade cardiac screening tool. It brings electrocardiography to the palm of your hand. It is a battery-free device that functions without internet and delivers the same accuracy as international machines at one-tenth the cost. 'It lets users take 12-lead ECG tests using a smartphone. It offers clinical-grade accuracy and real-time heart monitoring—ideal for home or on-the-go use", explains founder Rajat Jain from Dehradun. It has a user-friendly app that provides instant PDF reports and tracks the heart's rhythm 24/7 in real-time. Innergize Stress is a leading healthcare issue plaguing the country with more than 14 percent of the total population in India suffering from variations of mental disorders as per a Statista Research Department Report from December 2023. Stimulating the vagus nerve helps in reducing stress. The InnerGize wellness system from a Bengaluru-based health-tech startup comprises a discreet wearable and an app that leverages Neuro-Acoustic Vagal Modulation technology that activates the vagus nerve which is responsible for the body's relaxation system. The mild buzzing of the wearable stimulates the nerve, shifting the brain from 'fight-or-flight' to 'rest-and-recovery'. Long-term use of InnerGize trains the nerve to build a natural resistance to stress. The wearable is non-invasive, and people can use it at their discretion though it is recommended to be used daily for ten minutes. The InnerGize wearable is recommended for adults of all ages. However, those under the age of 18 and over the age of 65 should consult their healthcare providers before using any bioelectronic device. Nerivio Nerivio from Dr Reddy's is a smartphone-controlled wearable migraine band using REN technology that releases powerful signals to reduce or eliminate pain. It is a prescription-based non-invasive device intended for acute and preventive treatment of migraine for adults and adolescents aged 12 years and above. The technology gently stimulates nerve fibers in your upper arm and these signals tell the brain's pain control center to spring into action. It kick starts the body's pain-dampening system which in turn triggers the release of natural brain chemicals that block pain resulting in a widespread soothing effect, alleviating migraine pain. Each device has in-built 18, 45-minute treatment sessions. It is to be used within 60 minutes of the onset of headache for acute treatment of migraine or every alternate day. Shravan Shravan by Dozee is an AI-powered, contactless remote health monitoring service designed to help families and caregivers keep track of their elders' health. The system uses a sensor mat placed under the mattress to continuously track vital signs such as heart rate, respiration rate, non-contact blood pressure, and sleep patterns without requiring the elderly to wear any devices. This unobtrusive approach ensures that their daily routines remain undisturbed while providing caregivers and healthcare professionals with real-time insights. The system provides real-time alerts, integrates with hospitals, and ensures complete data privacy. With a user-friendly interface and remote access, Shravan enables timely medical intervention while allowing the elderly to maintain their daily routines uninterrupted.
Time of India
01-05-2025
- Health
- Time of India
Health indicators improve in Trichy, still trails state average
Trichy: Key health indicators in Tamil Nadu, including the Maternal Mortality Rate (MMR) and Infant Mortality Rate (IMR), continue to show improvement, with Trichy district reflecting a similar trend. However, the district's figures remain above the state average. Data from the Trichy district health office shows maternal mortality declined from 67.5 to 45.6 per one lakh live births between 2023–24 and 2024–25 (April to March). The IMR saw a marginal drop from 10.8 to 10.5 during the same period. Live births in the district also fell slightly, from 32,569 to 30,716. Statewide, 320 maternal deaths were reported in 2024–25, of which 14 occurred in Trichy. Out of more than 6,000 infant deaths in Tamil Nadu, 321 were from Trichy. Health officials attribute the improvement to enhanced maternal and childcare services, particularly the district-level 'war rooms' and home-based care programmes. Trichy's war room, located at the district collectorate, makes around 300 calls daily to track high-risk pregnancies. From the 35th week of gestation, officials ensure weekly follow-ups, checking for anaemia, nutrition, and other health markers. Women are advised to get admitted to nearby health centres about 10 days before their expected delivery. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like How can a 3-month-old get cancer? Please help! Give Hope India Donate Now Undo For newborn care, the Home-Based Newborn Care (HBNC) and Home-Based Care for Young Children (HBYC) schemes have been pivotal. Under HBNC, health nurses make six home visits within the first 45 days after birth. HBYC adds five more visits over the next 18 months. These check-ups cover early signs of illness, low birth weight, developmental delays, breastfeeding guidance, immunisation, and nutrition. Despite these efforts, Trichy's MMR (45.6) and IMR (10.5) remain higher than the state averages of 39.6 and 7.5, respectively. "There has been a consistent decline, and the trend is encouraging," a senior district health official told TOI. "Our goal is to match or surpass the state average in the coming year." Other indicators, such as the sex ratio and stillbirth rate, have also improved. The sex ratio at birth, which dipped to 933 females per 1,000 males in 2023–24, has returned to 948 in 2024–25 — the same level as in 2022–23. Officials dismissed speculation linking the earlier dip to sex-selective abortions, citing increased surveillance of scan centres and early registration of pregnant women on the PICME portal. "There have been no complaints in the past year. Regular awareness campaigns against sex-selective abortion are also ongoing," the official said.
Yahoo
18-03-2025
- Business
- Yahoo
Horizon Bancorp Full Year 2024 Earnings: Misses Expectations
Revenue: US$186.2m (up 1.9% from FY 2023). Net income: US$35.4m (up 27% from FY 2023). Profit margin: 19% (up from 15% in FY 2023). The increase in margin was primarily driven by lower expenses. EPS: US$0.81 (up from US$0.64 in FY 2023). Net interest margin (NIM): 2.68% (up from 2.54% in FY 2023). Non-performing loans: 0.56% (up from 0.46% in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 18%. Earnings per share (EPS) also missed analyst estimates by 4.1%. In the last 12 months, the only revenue segment was Commercial Banking contributing US$186.2m. The largest operating expense was General & Administrative costs, amounting to US$129.8m (86% of total expenses). Explore how HBNC's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 7.4% growth forecast for the Banks industry in the US. Performance of the American Banks industry. The company's shares are up 2.0% from a week ago. Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Horizon Bancorp that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
